| ISIN | CH0137596661 |
|---|---|
| Valor Number | 13759666 |
| Bloomberg Global ID | BBG0025YH505 |
| Fund Name | Bellevue Healthcare Strategy I |
| Fund Provider |
Bellevue Asset Management AG
Zürich, Switzerland Phone: +41 44 267 67 00 E-Mail: info@bellevue.ch Web: www.bellevue.ch |
| Fund Provider | Bellevue Asset Management AG |
| Representative in Switzerland | |
| Distributor(s) |
Zürcher Kantonalbank Zürich Phone: +41 44 293 93 93 |
| Asset Class | Equities |
| EFC Category | |
| Distribution Policy | Accumulation |
| Home Country | Switzerland |
| Issuing Condition | Special conditions apply to the issue of units |
| Redemption Condition | Special conditions apply to the redemption of units |
| Investment Strategy *** | N/A |
| Peculiarities |
| Current Price * | 3,433.94 CHF | 20.01.2026 |
|---|---|---|
| Previous Price * | 3,527.91 CHF | 16.01.2026 |
| 52 Week High * | 3,713.92 CHF | 30.01.2025 |
| 52 Week Low * | 3,079.28 CHF | 11.04.2025 |
| NAV * | 3,433.94 CHF | 20.01.2026 |
| Issue Price * | ||
| Redemption Price * | ||
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 44,258,587 | |
| Unit/Share Assets *** | 21,046,033 | |
| Trading Information SIX | ||
| YTD Performance | +0.76% |
31.12.2025 - 20.01.2026
31.12.2025 20.01.2026 |
|---|---|---|
| 1 month | +0.46% |
22.12.2025 - 20.01.2026
22.12.2025 20.01.2026 |
| 3 months | +2.51% |
20.10.2025 - 20.01.2026
20.10.2025 20.01.2026 |
| 6 months | +8.68% |
21.07.2025 - 20.01.2026
21.07.2025 20.01.2026 |
| 1 year | -5.03% |
21.01.2025 - 20.01.2026
21.01.2025 20.01.2026 |
| 2 years | +1.72% |
22.01.2024 - 20.01.2026
22.01.2024 20.01.2026 |
| 3 years | -8.48% |
20.01.2023 - 20.01.2026
20.01.2023 20.01.2026 |
| 5 years | -9.99% |
20.01.2021 - 20.01.2026
20.01.2021 20.01.2026 |
| Equity Participation Rate in % | 96.06 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | 0.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | 1.20 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | 20.01.2026 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Eli Lilly and Co | 3.03% | |
|---|---|---|
| Johnson & Johnson | 3.03% | |
| UnitedHealth Group Inc | 2.95% | |
| Abbott Laboratories | 2.94% | |
| Danaher Corp | 2.87% | |
| Boston Scientific Corp | 2.51% | |
| AbbVie Inc | 2.51% | |
| Intuitive Surgical Inc | 2.02% | |
| IDEXX Laboratories Inc | 2.01% | |
| Edwards Lifesciences Corp | 2.00% | |
| Last data update | 30.11.2025 | |
| TER | 0.81% |
|---|---|
| TER date | 30.09.2024 |
| Performance Fee *** | |
| PTR | |
| Max. Management Fee *** | 0.80% |
| Ongoing Charges *** | |
|
SRRI ***
|
|
| SRRI date *** | 31.12.2025 |